☆ 4.8 Article

Aurora Kinase B-Instruct Release of AZD1152-HQPA from Hydrogel to Enhance Cervical Cancer Suppression

ADVANCED FUNCTIONAL MATERIALS (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Multifunctional Supramolecular Filament Hydrogel Boosts Anti-Inflammatory Efficacy In Vitro and In Vivo

Jie Deng et al.

Summary: This study combines an antioxidant, a non-steroidal anti-inflammatory drug, and a self-assembled peptide to form a hydrogel that reduces the production of inflammatory mediators. It demonstrates superior therapeutic efficacy in an animal model compared to clinically used drugs.

ADVANCED FUNCTIONAL MATERIALS (2022)

Add to Collection

Review Nanoscience & Nanotechnology

Clinical translation of long-acting drug delivery formulations

Wei Li et al.

Summary: Long-acting drug delivery formulations enable sustained and prolonged drug release, improving patient compliance. This review discusses FDA-approved long-acting drug delivery formulations, including different slow-release mechanisms and materials, and provides a comprehensive summary of their clinical applications and product information.

NATURE REVIEWS MATERIALS (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Salt-Inducible Kinase 2-Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis

Yue Hua et al.

Summary: In this study, a supramolecular hydrogel capable of responsive release of a SIK2 inhibitor was developed for ovarian cancer therapy. Cell and animal experiments demonstrated its therapeutic efficacy and potential clinical application.

ADVANCED SCIENCE (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Trident Molecule with Nanobrush-Nanoparticle-Nanofiber Transition Property Spatially Suppresses Tumor Metastasis

Ge Gao et al.

Summary: By designing smart multifunctional prodrugs, we propose a novel strategy of intracellular enzymatic nanofiber formation and synergistic autophagy inhibition-enhanced chemotherapy and immunotherapy for spatial suppression of tumor metastasis. Meanwhile, the released CPT and HCQ synergistically induce a prominent therapeutic effect through autophagy inhibition-enhanced chemotherapy. Furthermore, chemotherapy of Nap-CPT-HCQ-Yp enhances immunogenic cell death, resulting in the activation of toxic T-cells.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Add to Collection

Review Engineering, Biomedical

Intracellular Self-Assembly of Peptide Conjugates for Tumor Imaging and Therapy

Yu Deng et al.

Summary: Intracellular self-assembly (ISA) is a powerful strategy for constructing complex nanostructures in cells, and has been widely applied in biomedicine and biomedical engineering. Using peptide conjugates for ISA in tumor imaging and treatment has made significant progress, with potential for other important imaging or therapeutic applications.

ADVANCED HEALTHCARE MATERIALS (2021)

Add to Collection

Review Pharmacology & Pharmacy

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming

Luciana Mosca et al.

Summary: Taxanes have been widely used as microtubule-targeting antitumor agents since 1984, showing impacts on key molecular mechanisms and cellular processes in cancer treatment. Research into the diverse effects and molecular mechanisms of taxanes may lead to more rational and efficacious applications, as well as novel strategies to overcome drug resistance in cancer therapy.

DRUG RESISTANCE UPDATES (2021)

Add to Collection

Article Engineering, Biomedical

Receptor tyrosine kinases-instructed release of its inhibitor from hydrogel to delay ovarian aging

Zhonghua Shi et al.

Summary: The development of a new hydrogel Gel Y + Inh provides a smart strategy to delay ovarian aging by releasing Inh that moderately inhibits mTOR activity. Experimental results in oocytes and zygotes show improvement in meiotic maturation and early embryonic development with Gel Y + Inh treatment.

BIOMATERIALS (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Translational Applications of Hydrogels

Santiago Correa et al.

Summary: Advances in hydrogel technology have led to diverse applications in medicine and environmental engineering, providing solutions for various diseases and medical conditions. Collaboration across disciplines is essential for the development of contemporary hydrogels to accomplish complex biological tasks in different fields.

CHEMICAL REVIEWS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Soft Materials by Design: Unconventional Polymer Networks Give Extreme Properties

Xuanhe Zhao et al.

Summary: Hydrogels possess extreme mechanical properties and have diverse applications. While many hydrogels have been developed, a set of general principles for designing them for various applications remains a central need.

CHEMICAL REVIEWS (2021)

Add to Collection

Review Oncology

Cervical Cancer Immunotherapy: Facts and Hopes

Louise Ferrall et al.

Summary: Cervical cancer, primarily caused by persistent high-risk HPV infection, remains the fourth most common cancer affecting women worldwide. Current treatments, such as radiotherapy, chemotherapy, and surgical resection, have limited efficacy and significant side effects against advanced disease. Immunotherapy shows promise in reversing immunosuppressive environments and enhancing T-cell functioning to improve treatment success.

CLINICAL CANCER RESEARCH (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer

Naheed Arfin Borah et al.

Summary: AURKB plays a critical role in tumor development, therapy-related drug resistance, and its inhibition as a potential therapeutic strategy for cancer. Its dysregulation is associated with malignant growth of tumors.

MOLECULES (2021)

Add to Collection

Review Pharmacology & Pharmacy

Vaginal drug delivery approaches for localized management of cervical cancer

Xue Wang et al.

Summary: Traditional methods for treating cervical cancer may have complications, leading to interest in new pharmaceutical forms based on nanotechnology. Vaginal drug delivery, with advantages like mucosa penetration and controlled drug release, is becoming a focus for the treatment of cervical cancer.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Selective Degradation of PD-L1 in Cancer Cells by Enzyme-Instructed Self-Assembly

Yuhan Wang et al.

Summary: A novel strategy utilizing self-assembly between ALP and PD-L1 to selectively degrade PD-L1 in tumor cells is reported. This strategy selectively encapsulates PD-L1 in nanomaterials for further degradation, showing potential for inhibiting tumor growth in animal models.

ADVANCED FUNCTIONAL MATERIALS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Bioinspired Intrinsic Versatile Hydrogel Fabricated by Amyloidal Toxin Simulant-Based Nanofibrous Assemblies for Accelerated Diabetic Wound Healing

Qize Xuan et al.

Summary: This study investigated a versatile hydrogel based on amyloid-derived toxin simulant, which promotes angiogenesis, has broad-spectrum antibacterial activity, and accelerates wound healing for diabetic patients, showing great potential for clinical application.

ADVANCED FUNCTIONAL MATERIALS (2021)

Add to Collection

Review Chemistry, Multidisciplinary

Structurally Dynamic Hydrogels for Biomedical Applications: Pursuing a Fine Balance between Macroscopic Stability and Microscopic Dynamics

Kunyu Zhang et al.

Summary: Hydrogels are gaining increasing attention in biomedical studies due to their unique chemical and physical properties. Dynamic hydrogels, which can better mimic the functions of natural extracellular matrix, have shown promise in applications such as regenerative medicine and drug delivery. Recent research has focused on the fabrication strategies and unique properties of dynamic hydrogels, as well as discussing challenges and emerging trends in their development and application.

CHEMICAL REVIEWS (2021)

Add to Collection

Article Medicine, General & Internal

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

N. Colombo et al.

Summary: Adding pembrolizumab to chemotherapy significantly improves progression-free and overall survival in patients with persistent, recurrent, or metastatic cervical cancer when compared to placebo. Anemia and neutropenia are the most common grade 3 to 5 adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker-based immunotherapy

Feihu Wang et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Cell Biology

Viral-Mediated AURKB Cleavage Promotes Cell Segregation and Tumorigenesis

Qing Zhu et al.

CELL REPORTS (2019)

Add to Collection

Article Multidisciplinary Sciences

AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy

Jordi Bertran-Alamillo et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Medicine, General & Internal

Cervical cancer

Paul A. Cohen et al.

LANCET (2019)

Add to Collection

Review Oncology

Systemic therapy for cervical carcinoma - current status

Krystyna Serkies et al.

CHINESE JOURNAL OF CANCER RESEARCH (2018)

Add to Collection

Article Chemistry, Multidisciplinary

Immune Responsive Release of Tacrolimus to Overcome Organ Transplant Rejection

Jindao Wu et al.

ADVANCED MATERIALS (2018)

Add to Collection

Article Medicine, General & Internal

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari et al.

LANCET (2017)

Add to Collection

Review Oncology

Cervical Cancer: A Global Health Crisis

William Small et al.

CANCER (2017)

Add to Collection

Review Pharmacology & Pharmacy

Injectable hydrogel-based drug delivery systems for local cancer therapy

Mohammad Norouzi et al.

DRUG DISCOVERY TODAY (2016)

Add to Collection

Article Oncology

Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases

Patrizia Sini et al.

MOLECULAR CANCER THERAPEUTICS (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials

Xuewen Du et al.

CHEMICAL REVIEWS (2015)

Add to Collection

Article Oncology

Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505

Ryo Kitagawa et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy

Andras Micsonai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Add to Collection

Article Oncology

A Cell Biologist's Field Guide to Aurora Kinase Inhibitors

Christian O. de Groot et al.

FRONTIERS IN ONCOLOGY (2015)

Add to Collection

Review Biochemistry & Molecular Biology

The aurora kinases in cell cycle and leukemia

B. Goldenson et al.

ONCOGENE (2015)

Add to Collection

Article Oncology

Stage I of a phase 2 study assessing the efficacy, safety, and tolerability of barasertib (AZD1152) versus low-dose cytosine arabinoside in elderly patients with acute myeloid leukemia

Hagop M. Kantarjian et al.

CANCER (2013)

Add to Collection

Article Hematology

Phase 1/2 study to assess the safety, efficacy, and pharmacokinetics of barasertib (AZD1152) in patients with advanced acute myeloid leukemia

Bob Lowenberg et al.

BLOOD (2011)

Add to Collection

Review Oncology

Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?

Altaf A. Dar et al.

MOLECULAR CANCER THERAPEUTICS (2010)

Add to Collection

Article Oncology

GSK1070916, a potent Aurora B/C kinase inhibitor with broad antitumor activity in tissue culture cells and human tumor xenograft models

Mary Ann Hardwicke et al.

MOLECULAR CANCER THERAPEUTICS (2009)

Add to Collection

Review Oncology

Molecular mechanisms of resistance and toxicity associated with platinating agents

Cara A. Rabik et al.

CANCER TREATMENT REVIEWS (2007)

Add to Collection

Review Oncology

Aurora kinases: New targets for cancer therapy

Richard D. Carvajal et al.

CLINICAL CANCER RESEARCH (2006)

Add to Collection

Article Cell Biology

Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores

C Ditchfield et al.

JOURNAL OF CELL BIOLOGY (2003)

Add to Collection

Review Cell Biology

Mitotic kinases as regulators of cell division and its checkpoints

EA Nigg

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.